Peer-influenced content. Sources you trust. No registration required. This is HCN.
Anesthesiology News
The evolving use of dopamine D2-receptor antagonists, marked by safety concerns and an FDA black box warning on droperidol, has seen a resurgence with the FDA-approved amisulpride, highlighting the need for further research to explore its comparison with other antiemetics and its role in multimodal PONV management.
Anesthesiology July 20th 2023
CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH